IGC Pharma Inc
IGC
Get informed when a big investor buys or sells
+ FollowMarket Cap$28.92M
Close$
$-0.11
137% downside
Current Fair Value
137% downsideOvervalued by 137% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $28.92 Million |
|---|---|
| Enterprise Value | $28.71 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.07 |
| Beta | 0.5 |
| Outstanding Shares | 95,038,026 |
Return
| Return on Equity | -106.98% |
|---|---|
| Return on Assets | -71.29% |
| Return on Invested Capital | -144.57% |
Valuation & Multiples
| P/E Ratio | -4.19 |
|---|---|
| PEG | -4.17 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 24.21 |
| Enterprise Value to EBIT | -3.15 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
April 3, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$250,000
Average shareholder expectationNext Earnings Call
Expected Date
June 15, 2026
EPS Estimate
$-0.03
Average shareholder expectationRevenue Estimate
$198,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.56%▼ 0.78% |
|---|---|
| Total Invested | $1.14M▼ 16.18% |
| Investors Holding | 35▲ 5.00% |
ESG Score
No data
About India Globalization Capital Inc
CEO: Ram Mukunda